Company · Ownership research

OCULAR THERAPEUTIX, INC OCUL

CIK 0001393434

Form 4 transactions dated Sep 1, 2023 to Sep 26, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

Insider filings on file run through 2026-09-02.

Insider purchases & sales

Purchased: $12.53M
Sold: $5.48M

Sep 1, 2023 – Sep 2, 2026
Available records · partial months are marked ·

202510 of 25 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
2025-11-24	Nayak Sanjay Chief Strategy Officer	Sale	$22.61K 1,878 shares sold	0.67% sold Direct holding	▾
2025-11-24	Dugel Pravin See Remarks · Director	Sale	$235.14K 19,530 shares sold	0.61% sold Direct holding	▾
2025-11-24	Kaiser Peter Chief Development Officer	Sale	$36.14K 3,007 shares sold	1.55% sold Direct holding	▾
2025-11-24	Heier Jeffrey S. Chief Scientific Officer	Sale	$41.77K 3,469 shares sold	1.39% sold Direct holding	▾
2025-11-05	Saroj Namrata Chief Business Officer	Sale	$277.79K 25,865 shares sold	12.93% sold Direct holding	▾
2025-10-08	Anderman Todd Chief Legal Officer	Sale	$137.37K 11,132 shares sold	11.28% sold Direct holding	▾
2025-10-02	Kaiser Peter Chief Development Officer	Sale	$106.47K 9,653 shares sold	4.73% sold Direct holding	▾
2025-10-02	Heier Jeffrey S. Chief Scientific Officer	Sale	$115.94K 10,502 shares sold	4.04% sold Direct holding	▾
2025-09-02	Notman Donald See Remarks	Sale	$13.25K 1,066 shares sold	0.34% sold Direct holding	▾
2025-08-25	Kaiser Peter Chief Development Officer	Sale	$36.25K 3,011 shares sold	1.45% sold Direct holding	▾

Showing 25 / 25 record groups in 2025. The complete set is available through the API.

OCULAR THERAPEUTIX, INC · OCUL

Follow the people behind the trades.

Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 25 of 25 purchase / sale groups and 29 of 29 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

list_insider_transactions
{"ticker":"OCUL","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.